文献速递儿科影像神经PETCT

68Ga标记DOTANOC PET/CT在小儿副肿瘤性眼阵挛肌阵挛共济失调综合征患者中的诊断价值

Diagnostic values of 68Ga-labelled DOTANOC PET/CT imaging in pediatric patients presenting with paraneoplastic opsoclonus myoclonus ataxia syndrome.
PubMed 文献 · Eur Radiol · 2021-01-06

回顾性分析2012年3月至2018年11月38例眼阵挛肌阵挛共济失调综合征患儿的68Ga-DOTANOC PET/CT资料,以组织病理学和/或临床/影像随访(至少一年)为参考标准,18例(47.3%)存在生长抑素受体表达病灶,PET/CT诊断神经母细胞瘤的敏感度100%、特异度95.2%、阳性预测值94.4%、阴性预测值100%、准确率97.3%。

要点

  • 在眼阵挛肌阵挛共济失调综合征患儿中,68Ga-DOTANOC PET/CT检出神经源性肿瘤的敏感度为100%、特异度为95.2%、准确率为97.3%。
  • PET阳性定义为生长抑素受体表达病灶伴CT对应形态学改变,PET阴性定义为无异常生长抑素受体表达或病灶。
  • 38例中18例(47.3%)PET阳性,其中17例经组织病理学证实为神经源性肿瘤,1例为反应性增生。

关键影像表现/征象

  • PET阳性定义为生长抑素受体表达病灶伴CT图像上对应的形态学改变,PET阴性定义为未见异常生长抑素受体表达或病灶。
  • PET阳性病灶的平均SUVmax为10.3(范围2.8-34.5)。

诊断标准与关键数值

  • 以组织病理学和/或临床/影像随访(至少一年)为参考标准,68Ga-DOTANOC PET/CT检出神经源性肿瘤的敏感度为100%、特异度为95.2%、阳性预测值为94.4%、阴性预测值为100%、准确率为97.3%。
  • PET/CT结果包括17例真阳性、1例假阳性、20例真阴性和0例假阴性。

临床应用与阅片要点

  • 在眼阵挛肌阵挛共济失调综合征患儿中,68Ga-DOTANOC PET/CT可检出生长抑素受体表达的神经源性肿瘤病灶。
  • PET阳性判读需结合CT上的对应形态学改变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Opsoclonus myoclonus ataxia (OMA) syndrome, also known as "Kinsbourne syndrome" or "dancing eye syndrome," is a rare, paraneoplastic entity which may be associated with pediatric neuroblastic tumors and carry a grave prognosis. We aimed to evaluate the role of 68Ga DOTANOC PET/CT for detecting neuroblastic tumors in patients with OMA syndrome.

METHODS: We retrospectively evaluated the 68Ga-DOTANOC PET/CT data of pediatric patients presenting with OMA syndrome from March 2012 to November 2018. A somatostatin receptor (SSTR)-expressing lesion with corresponding morphological change on CT image was considered PET-positive, while no abnormal SSTR expression or lesion was noticed in PET-negative patients. Histopathology and/or clinical/imaging follow-up (minimum one year) was considered a reference standard for comparing the PET/CT findings. The results of 68Ga-DOTANOC PET/CT were also compared with 131I MIBG whole-body scintigraphy, which was available in five patients.

RESULTS: Of 38 patients (13 males, 25 females, aged 3-96 months), 18 (47.3%) had SSTR-expressing lesions (PET-positive), and histopathology revealed neuroblastic tumors in 17/18 lesions (neuroblastoma 14, ganglioneuroblastoma 2, and ganglioneuroma 1) and reactive hyperplasia in 1/18. The remaining 20/38 (52.6%) patients did not demonstrate SSTR-expressing lesions (PET-negative) and had an uneventful follow-up. The average SUVmax of the PET-positive lesions was 10.3 (range 2.8-34.5). The PET/CT results revealed 17 true-positive, one false-positive, 20 true-negative, and zero false-negative. The sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 100%, 95.2%, 94.4%, 100%, and 97.3% respectively.

CONCLUSIONS: 68Ga-DOTANOC PET/CT identified neuroblastic tumors with a high diagnostic accuracy in our cohort compared to histology and follow-up.

KEY POINTS: • Opsoclonus myoclonus ataxia (OMA) syndrome or "dancing eye syndrome" is a rare paraneoplastic entity which may be associated with pediatric neuroblastic tumors with a grave prognosis. • 123I/131I MIBG imaging has a proven role for functional imaging in neuroblastoma or patients with OMA, but the role of 68Ga-DOTANOC PET/CT is not yet studied. • 68Ga-labelled DOTANOC PET/CT (SSTR) imaging, in our cohort, was able to positively identify neuroblastic tumors with high diagnostic accuracy when compared with histology.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kumar R, Vankadari K, Mittal BR, et al. Diagnostic values of 68Ga-labelled DOTANOC PET/CT imaging in pediatric patients presenting with paraneoplastic opsoclonus myoclonus ataxia syndrome. Eur Radiol. 2021. PMID: 33409780. doi:10.1007/s00330-020-07587-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。